Lowering drug prices and enhancing pharmaceutical affordability: an analysis of the national volume-based procurement (NVBP) effect in China
Guardado en:
Autores principales: | Bin Jiang, Z Kevin Lu, Xiaomo Xiong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/194c81f09dbd4beb92927c4c7200bc95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Will the Volume-Based Procurement Policy Promote Pharmaceutical Firms’ R&D Investment in China? An Event Study Approach
por: Yuanyuan Hu, et al.
Publicado: (2021) -
The impact of “4 + 7” volume-based drug procurement on the volume, expenditures, and daily costs of antihypertensive drugs in Shenzhen, China: an interrupted time series analysis
por: Ying Yang, et al.
Publicado: (2021) -
Measuring access to medicines: a survey of prices, availability and affordability in Shaanxi province of China.
por: Minghuan Jiang, et al.
Publicado: (2013) -
Simulation of Optimum Offer Prices in the Contract System in State and Municipal Procurement
por: A. N. Kislyakov
Publicado: (2019) -
Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.
por: Nkeiruka Grace Osuafor, et al.
Publicado: (2021)